Viewing Study NCT03164993


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-31 @ 8:06 PM
Study NCT ID: NCT03164993
Status: COMPLETED
Last Update Posted: 2024-10-15
First Post: 2017-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer
Sponsor: Oslo University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module